Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu
Asics made in Indonosia

Asics Gel - Contend 5 Men's Running Shoes - Blue Expanse/Sour Yuzu

Regular price Rs. 4,499.00 Sale price Rs. 3,899.00

Product Description

Go further than ever before with the men's GEL-CONTEND 5 running shoe by ASICS, created to offer the energized cushioning and stability required to clock up those extra miles. The GEL-CONTEND 5 shoe offers a supportive fit thanks to an internal heel counter, while rearfoot GEL technology and the AMPLIFOAM midsole ensure your feet remain cushioned and comfortable every step of the way. A solid rubber outsole gives this shoe a high level of durability, while the athletic mesh and removable ORTHOLITE sockliner help you stay fresher for longer as you take on new challenges. You can rest assured that the GEL-CONTEND 5 shoe will give you comfort and protection when you need it most. Weight

Product Tech & Materials

  • AmpliFoam Midsole
    Engineered to maintain durability at softer densities, providing better flexibility, comfort, and platform adaptability ideal for natural running.
  • Rearfoot GEL technology cushioning system
    Attenuates shock during impact phase and allows for a smooth transition to midstance.
  • Ortholite Sockliner
    Moisture management (Ortholite is a registered trademark of O2 Partners LLC).
  • Ortholite X-40 Sockliner
    This premium sockliner features higher rebound properties while providing excellent moisture management and a high-level of breathability (Ortholite is a registered trademark of O2 Partners LLC.)